In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Cardinal Health, Inc’s stock clocked out at $207.38, down -0.44% from its previous closing price of $208.29. In other words, the price has decreased by -$0.44 from its previous closing price. On the day, 0.77 million shares were traded. CAH stock price reached its highest trading level at $208.51 during the session, while it also had its lowest trading level at $207.13.
Ratios:
To gain a deeper understanding of CAH’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.07. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 0.96.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on December 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $243.
On June 03, 2025, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight but kept the price unchanged to $179.
Jefferies Upgraded its Hold to Buy on February 05, 2025, whereas the target price for the stock was revised from $140 to $150.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 20 ’25 when WEITZMAN DEBORAH bought 21,367 shares for $150.53 per share.
WEITZMAN DEBORAH sold 21,367 shares of CAH for $3,216,375 on Aug 20 ’25. The CEO, PSS Segment now owns 53,428 shares after completing the transaction at $150.53 per share. On Aug 20 ’25, another insider, Hollar Jason M., who serves as the Chief Executive Officer of the company, sold 35,901 shares for $150.04 each. As a result, the insider received 5,386,566 and left with 200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAH now has a Market Capitalization of 49272459264 and an Enterprise Value of 53859459072. As of this moment, Cardinal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.31, and their Forward P/E ratio for the next fiscal year is 18.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21. Its current Enterprise Value per Revenue stands at 0.23 whereas that against EBITDA is 15.197.
Stock Price History:
The Beta on a monthly basis for CAH is 0.65, which has changed by 0.76113975 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, CAH has reached a high of $214.93, while it has fallen to a 52-week low of $117.53. The 50-Day Moving Average of the stock is 6.24%, while the 200-Day Moving Average is calculated to be 28.34%.
Shares Statistics:
It appears that CAH traded 2.45M shares on average per day over the past three months and 2174130 shares per day over the past ten days. A total of 238.00M shares are outstanding, with a floating share count of 237.00M. Insiders hold about 0.25% of the company’s shares, while institutions hold 90.30% stake in the company. Shares short for CAH as of 1765756800 were 4904967 with a Short Ratio of 2.00, compared to 1763078400 on 8047562. Therefore, it implies a Short% of Shares Outstanding of 4904967 and a Short% of Float of 2.3800000000000003.
Dividends & Splits
With its trailing 12-month dividend rate of 2.033, CAH has a forward annual dividend rate of 2.03. Against a Trailing Annual Dividend Yield of 0.00976043. The stock’s 5-year Average Dividend Yield is 2.5. The current Payout Ratio is 31.43% for CAH, which recently paid a dividend on 2025-10-01 with an ex-dividend date of 2026-01-02. Stock splits for the company last occurred on 2001-04-23 when the company split stock in a 3:2 ratio.
Earnings Estimates
A detailed examination of Cardinal Health, Inc (CAH) is currently in progress, with 15.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $2.69, with high estimates of $2.93 and low estimates of $2.52.
Analysts are recommending an EPS of between $10.18 and $9.74 for the fiscal current year, implying an average EPS of $9.83. EPS for the following year is $11.08, with 16.0 analysts recommending between $11.44 and $10.82.
Revenue Estimates
In. The current quarter, 13 analysts expect revenue to total $64.88B. It ranges from a high estimate of $66.24B to a low estimate of $63.97B. As of. The current estimate, Cardinal Health, Inc’s year-ago sales were $55.26BFor the next quarter, 13 analysts are estimating revenue of $62.77B. There is a high estimate of $64.49B for the next quarter, whereas the lowest estimate is $60.67B.
A total of 14 analysts have provided revenue estimates for CAH’s current fiscal year. The highest revenue estimate was $263.87B, while the lowest revenue estimate was $255.37B, resulting in an average revenue estimate of $258.34B. In the same quarter a year ago, actual revenue was $222.58BBased on 14 analysts’ estimates, the company’s revenue will be $279.86B in the next fiscal year. The high estimate is $290.02B and the low estimate is $269.22B.
